185 related articles for article (PubMed ID: 29935087)
1. Efficacy and safety of a clinically relevant foamy vector design in human hematopoietic repopulating cells.
Everson EM; Hocum JD; Trobridge GD
J Gene Med; 2018 Jul; 20(7-8):e3028. PubMed ID: 29935087
[TBL] [Abstract][Full Text] [Related]
2. Evidence for the in vivo safety of insulated foamy viral vectors.
Browning DL; Everson EM; Leap DJ; Hocum JD; Wang H; Stamatoyannopoulos G; Trobridge GD
Gene Ther; 2017 Mar; 24(3):187-198. PubMed ID: 28024082
[TBL] [Abstract][Full Text] [Related]
3. Insulated Foamy Viral Vectors.
Browning DL; Collins CP; Hocum JD; Leap DJ; Rae DT; Trobridge GD
Hum Gene Ther; 2016 Mar; 27(3):255-66. PubMed ID: 26715244
[TBL] [Abstract][Full Text] [Related]
4. Foamy-virus-mediated gene transfer to canine repopulating cells.
Kiem HP; Allen J; Trobridge G; Olson E; Keyser K; Peterson L; Russell DW
Blood; 2007 Jan; 109(1):65-70. PubMed ID: 16968897
[TBL] [Abstract][Full Text] [Related]
5. Foamy viral vector integration sites in SCID-repopulating cells after MGMTP140K-mediated in vivo selection.
Olszko ME; Adair JE; Linde I; Rae DT; Trobridge P; Hocum JD; Rawlings DJ; Kiem HP; Trobridge GD
Gene Ther; 2015 Jul; 22(7):591-5. PubMed ID: 25786870
[TBL] [Abstract][Full Text] [Related]
6. Large animal models for foamy virus vector gene therapy.
Trobridge GD; Horn PA; Beard BC; Kiem HP
Viruses; 2012 Dec; 4(12):3572-88. PubMed ID: 23223198
[TBL] [Abstract][Full Text] [Related]
7. Foamy virus vector-mediated gene correction of a mouse model of Wiskott-Aldrich syndrome.
Uchiyama T; Adriani M; Jagadeesh GJ; Paine A; Candotti F
Mol Ther; 2012 Jun; 20(6):1270-9. PubMed ID: 22215016
[TBL] [Abstract][Full Text] [Related]
8. Foamy Virus Vector Carries a Strong Insulator in Its Long Terminal Repeat Which Reduces Its Genotoxic Potential.
Goodman MA; Arumugam P; Pillis DM; Loberg A; Nasimuzzaman M; Lynn D; van der Loo JCM; Dexheimer PJ; Keddache M; Bauer TR; Hickstein DD; Russell DW; Malik P
J Virol; 2018 Jan; 92(1):. PubMed ID: 29046446
[TBL] [Abstract][Full Text] [Related]
9. Transduction of umbilical cord blood CD34+ NOD/SCID-repopulating cells by simian foamy virus type 1 (SFV-1) vector.
Zucali JR; Ciccarone T; Kelley V; Park J; Johnson CM; Mergia A
Virology; 2002 Oct; 302(2):229-35. PubMed ID: 12441067
[TBL] [Abstract][Full Text] [Related]
10. Comparison of three retroviral vector systems for transduction of nonobese diabetic/severe combined immunodeficiency mice repopulating human CD34+ cord blood cells.
Leurs C; Jansen M; Pollok KE; Heinkelein M; Schmidt M; Wissler M; Lindemann D; Von Kalle C; Rethwilm A; Williams DA; Hanenberg H
Hum Gene Ther; 2003 Apr; 14(6):509-19. PubMed ID: 12718762
[TBL] [Abstract][Full Text] [Related]
11. Long-term follow-up of foamy viral vector-mediated gene therapy for canine leukocyte adhesion deficiency.
Bauer TR; Tuschong LM; Calvo KR; Shive HR; Burkholder TH; Karlsson EK; West RR; Russell DW; Hickstein DD
Mol Ther; 2013 May; 21(5):964-72. PubMed ID: 23531552
[TBL] [Abstract][Full Text] [Related]
12. Preclinical Development of a Hematopoietic Stem and Progenitor Cell Bioengineered Factor VIII Lentiviral Vector Gene Therapy for Hemophilia A.
Doering CB; Denning G; Shields JE; Fine EJ; Parker ET; Srivastava A; Lollar P; Spencer HT
Hum Gene Ther; 2018 Oct; 29(10):1183-1201. PubMed ID: 30160169
[TBL] [Abstract][Full Text] [Related]
13. Stem cell selection in vivo using foamy vectors cures canine pyruvate kinase deficiency.
Trobridge GD; Beard BC; Wu RA; Ironside C; Malik P; Kiem HP
PLoS One; 2012; 7(9):e45173. PubMed ID: 23028826
[TBL] [Abstract][Full Text] [Related]
14. Foamy virus vectors for gene transfer.
Trobridge GD
Expert Opin Biol Ther; 2009 Nov; 9(11):1427-36. PubMed ID: 19743892
[TBL] [Abstract][Full Text] [Related]
15. Foamy and lentiviral vectors transduce canine long-term repopulating cells at similar efficiency.
Trobridge GD; Allen J; Peterson L; Ironside C; Russell DW; Kiem HP
Hum Gene Ther; 2009 May; 20(5):519-23. PubMed ID: 19199822
[TBL] [Abstract][Full Text] [Related]
16. High-titer foamy virus vector transduction and integration sites of human CD34(+) cell-derived SCID-repopulating cells.
Nasimuzzaman M; Kim YS; Wang YD; Persons DA
Mol Ther Methods Clin Dev; 2014; 1():14020. PubMed ID: 26015964
[TBL] [Abstract][Full Text] [Related]
17. A foamy virus vector system for stable and efficient RNAi expression in mammalian cells.
Papadaki M; Siapati EK; Vassilopoulos G
Hum Gene Ther; 2011 Oct; 22(10):1293-303. PubMed ID: 21456885
[TBL] [Abstract][Full Text] [Related]
18. Long-term engraftment of nonobese diabetic/severe combined immunodeficient mice with human CD34+ cells transduced by a self-inactivating human immunodeficiency virus type 1 vector.
Gatlin J; Padgett A; Melkus MW; Kelly PF; Garcia JV
Hum Gene Ther; 2001 Jun; 12(9):1079-89. PubMed ID: 11399229
[TBL] [Abstract][Full Text] [Related]
19. A comparison of foamy and lentiviral vector genotoxicity in SCID-repopulating cells shows foamy vectors are less prone to clonal dominance.
Everson EM; Olzsko ME; Leap DJ; Hocum JD; Trobridge GD
Mol Ther Methods Clin Dev; 2016; 3():16048. PubMed ID: 27579335
[TBL] [Abstract][Full Text] [Related]
20. Foamy virus vectors expressing anti-HIV transgenes efficiently block HIV-1 replication.
Taylor JA; Vojtech L; Bahner I; Kohn DB; Laer DV; Russell DW; Richard RE
Mol Ther; 2008 Jan; 16(1):46-51. PubMed ID: 17955023
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]